# LightDeck Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lightdeck-diagnostics

- Industry: Healthcare
- Headquarters: Boulder, US
- Website: www.lightdeckdx.com
- Total disclosed funding: $11M
- Latest round: Series B (Oct 29, 2020)
- Investors on record: 3

## About

LightDeck Diagnostics is a company specializing in advanced diagnostic solutions for healthcare applications, leveraging innovative technologies to enhance testing accuracy and efficiency.LightDeck Diagnostics, founded in 2009 in Boulder, US, focuses on developing diagnostic solutions that improve healthcare decision-making. The company has not undergone notable pivots or changes in operations. It was founded by Chris Myatt and Lachlan C, and its current CEO is Bob Silverman. The company raised USD 11 mn in Series B funding in October 2020, with investors including Boulder Ventures, Entrada Ventures, and Incubic. The total amount raised by the company is USD 11 mn.LightDeck Diagnostics offers a range of advanced diagnostic products, including proprietary tests designed for various health applications. These products are developed to deliver accurate, rapid results that aid in clinical decision-making. The company prioritizes innovation in its offerings, ensuring healthcare providers have access to reliable diagnostic tools tailored to meet specific needs.LightDeck Diagnostics generates revenue through direct sales of its diagnostic products and services to healthcare providers. The company's revenue model includes both one-time product purchases and ongoing service agreements. Key products are integral to its revenue structure, contributing to repeat business as healthcare facilities rely on consistent diagnostic capabilities.LightDeck Diagnostics plans to utilize the recent USD 11 mn Series B funding to expand its product line and enhance its market presence. The company is focused on launching new diagnostics products and entering new geographic markets, with particular attention on the North American healthcare sector. This expansion is aimed at providing advanced diagnostic solutions that align with evolving healthcare needs.

## Funding rounds

- Series B, Oct 29, 2020, $11M — Boulder Ventures, Incubic, Entrada Ventures

## Investors

- Boulder Ventures (https://capitalatlas.ai/funds/boulder-ventures) — Series B
- Incubic (https://capitalatlas.ai/funds/incubic) — Series B
- Entrada Ventures (https://capitalatlas.ai/funds/entrada-ventures) — Series B